What concentration of zinc oxide (ZnO) is recommended for treating burn irritation, 15% or 20%?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Zinc Oxide Concentration for Burn Irritation

For burn irritation and wound protection, use zinc oxide 20% concentration, as this is the FDA-approved formulation and is supported by clinical evidence showing effective wound healing and skin protection. 1

Evidence-Based Recommendation

The FDA-approved concentration of zinc oxide for topical use is 20%, which represents the standard formulation for skin protection and wound care 1. While the question asks specifically about 15% versus 20%, the clinical evidence and regulatory guidance support the 20% concentration.

Clinical Applications in Burn Care

Zinc oxide serves primarily as a protective barrier rather than a primary burn treatment agent:

  • Zinc oxide-based skin protectants are recommended for protecting peristomal skin from gastric content leakage, demonstrating its effectiveness as a barrier cream 2
  • In burn care protocols, zinc oxide paste is used to protect surrounding normal skin when applying other treatments like anthralin, preventing irritation to unaffected areas 2
  • Women undergoing phototherapy may shield nipples with zinc oxide paste as a physical blocker to prevent burning 2

Important Limitations and Cautions

Zinc oxide should not be used as a primary burn wound healing agent:

  • Research demonstrates that soluble zinc content as low as 10.5 μg/cm² can actually negate skin wound healing and cause irritation in burn wounds 3
  • A study examining zinc chloride solutions on partial thickness thermal burns found that even low concentrations (0.01% w/w) negated wound healing compared to untreated controls 3
  • The oxidative stress action of soluble zinc can disrupt skin homeostasis and cause pruritis and inflammation 3

Preferred Primary Burn Treatments

For actual burn wound management, evidence supports alternative treatments over zinc-based products:

  • Honey dressings show faster healing by 7.80 days on average (95% CI: -8.78 to -6.63) and lower complication rates (RR 0.13; 95% CI: 0.03-0.52) compared to silver sulfadiazine 4
  • Petrolatum-based antibiotic ointments like bacitracin or Polysporin combined with non-adherent dressings are recommended for superficial burns 5
  • Silver sulfadiazine is no longer recommended as first-line treatment due to increased infection rates (OR = 1.87; 95% CI: 1.09 to 3.19) and longer hospital stays 4, 6

Zinc Oxide Composite Formulations

Recent research on zinc oxide nanoparticle composites shows promise but requires further validation:

  • A zinc oxide/dimethicone spray formulation showed significantly faster healing time (12.16 ± 8.64 days) compared to silver sulfadiazine (16.89 ± 11.34 days) in pediatric perineal burns 7
  • Zinc oxide nanoparticles in composite hydrogels demonstrated accelerated wound healing in animal models by reducing inflammatory responses and promoting growth factors 8, 9
  • These formulations differ substantially from simple zinc oxide paste and should not be conflated with standard zinc oxide preparations 7

Practical Application Protocol

When using zinc oxide 20% for burn care:

  • Apply only to intact surrounding skin as a protective barrier, not directly to the burn wound itself 2
  • Use to prevent irritation from other topical treatments or bodily fluids 2
  • Do not use as a primary burn wound treatment agent given the evidence of potential healing impairment 3
  • Consider alternative primary treatments like honey dressings or petrolatum-based antibiotic ointments for the actual burn wound 4, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Burn Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of First-Degree Burns

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Silver Sulfadiazine for Burns: Efficacy, Limitations, and Alternative Treatments

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

A Retrospective Study of Touchless Spray for Pediatric Perineal Burns Treatment.

Journal of burn care & research : official publication of the American Burn Association, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.